×

HL7's new AMS is live!   We are working with Fonteva to resolve log in issues. My Account

Section 1a: Clinical Document Architecture (CDA®)
Section 3: Implementation Guides

HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm

DESCRIPTION

This document describes constraints on the Clinical Document Architecture Release 2 (CDA R2) header and body elements for the Clinical Oncology Treatment Plan and Summary (COTPS) documents, which are derived from the American Society of Clinical Oncology (ASCO).  This implementation guide contains the following document types:

  • Breast Cancer Adjuvant Treatment Plan and Summary (BCTPS)
  • Colon Cancer Adjuvant Treatment Plan and Summary (CCTPS)
  • Treatment Summary and Survivorship Care Plan (SCP)

Standardization of information used in these documents will promote interoperability and will create information suitable for reuse in quality measurement, public health, and research, and for reimbursement.

This guide contains a library of Clinical Document Architecture (CDA) templates, and is compliant with the Consolidated Clinical Document Architecture (C-CDA) R2.1 standard cited in Final Rules for Stage 3 Meaningful Use and ONC 2015 Certification rule.

ALTERNATIVE NAMES

HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm may also go by the following names or acronyms:

"HL7 IG for CDAR2: Clinical Oncology Patient Transfer Summary, R1", ASCO, Breast Cancer Treatment Plan and Summary, BCTPS, Colon Cancer Treatment Plan and Summary, CCTPS, Oncology Treatment Plan and Summary, COTPS

TARGETS

  • EHR,PHR Vendors
  • Health Care IT
  • Lab Vendors
  • Healthcare Institutions (hospitals, long term care, home care, mental health)

 

BENEFITS

  • Creates a library of templates based on CDA architecture to encourage greater capture and exchange of structured data.  Standardization of information in this form will promote interoperability and create information suitable for reuse in quality measurement, public health, research, and for reimbursement
  • Enables communication between health care providers while an oncology patient is receiving care by augmenting care with a limited summary of a patient’s care information during and/or after treatment
  • Supports reuse of information available in electronic health record systems through development of cancer-specific data standards

IMPLEMENTATIONS/CASE STUDIES

  • American Society of Clinical Oncology (ASCO)

RELATED DOCUMENTS

HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm

STU DOCUMENTS

HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary; Release 1, STU Release 3 - US Realm Expiration Oct 2018

(Download) (9.96 MB)

HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary; Release 1, DSTU Release 2.1 - US Realm Expiration Dec 2016

(Download) (6.34 MB)

HL7 Implementation Guide for CDA® Release 2: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm, DSTU Release 2 Expiration Dec 2016

(Download) (6.21 MB)

HL7 Implementation Guide for CDA® Release 2: Clinical Oncology Treatment Plan and Summary, Release 1 Expiration Nov 2015

(Download) (4.76 MB)

TOPICS

  • Clinical Statement
  • Laboratory
  • Medical Records
  • Patient Care
  • Pharmacy
  • Terminology

BALLOT TYPE

  • DSTU
  • STU

STATUS DATE

2021-06-30

RESPONSIBLE WORK GROUP

Structured Documents

STAKEHOLDERS

  • Healthcare Institutions
  • Lab Vendors

FAMILY

  • CDA

CURRENT STATE

  • Retired

REALM

  • US Realm